QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2017    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancer 期刊论文 2017, 卷号: 8, 期号: 20, 页码: 33796-33806 作者:  Wang, Zhijie;  Piha-Paul, Sarina;  Janku, Filip;  Subbiah, Vivek;  Shi, Naiyi 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 KRAS  TP53  chronic inflammation  phase I trial  gene aberration-related therapy   A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-02-01 作者:  Xu, Rui-hua;  Zhang, Dongsheng;  Shen, Lin;  Li, Jin;  Huang, Jing 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer. 期刊论文 2017, 卷号: 35, 期号: 4 作者:  Xu, Rui-hua;  Zhang, Dongsheng;  Shen, Lin;  Li, Jin;  Huang, Jing 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 期刊论文 2017, 卷号: 35 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04